These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26973199)

  • 21. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between lung adenocarcinoma histological subtype and patient prognosis.
    Urer HN; Kocaturk CI; Gunluoglu MZ; Arda N; Bedirhan MA; Fener N; Dincer SI
    Ann Thorac Cardiovasc Surg; 2014; 20(1):12-8. PubMed ID: 23364232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma.
    Ohtani-Kim SJ; Taki T; Tane K; Miyoshi T; Samejima J; Aokage K; Nagasaki Y; Kojima M; Sakashita S; Watanabe R; Sakamoto N; Goto K; Tsuboi M; Ishii G
    Mod Pathol; 2023 Sep; 36(9):100209. PubMed ID: 37149221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Oskarsdottir GN; Bjornsson J; Jonsson S; Isaksson HJ; Gudbjartsson T
    APMIS; 2016 May; 124(5):384-92. PubMed ID: 26957057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
    Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
    Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma.
    Yu Y; Ding Z; Jian H; Shen L; Zhu L; Lu S
    Cancer Med; 2016 Sep; 5(9):2323-31. PubMed ID: 27456862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma.
    Kim TH; Buonocore D; Petre EN; Durack JC; Maybody M; Johnston RP; Travis WD; Adusumilli PS; Solomon SB; Ziv E
    Ann Thorac Surg; 2019 Aug; 108(2):392-398. PubMed ID: 30986416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma.
    Suda K; Sato K; Shimizu S; Tomizawa K; Takemoto T; Iwasaki T; Sakaguchi M; Mitsudomi T
    Biomed Res Int; 2014; 2014():645681. PubMed ID: 25371901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
    Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
    Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between EGFR mutations and clinicopathological features of lung adenocarcinomas diagnosed via small biopsies.
    Kim HJ; Choi EY; Jin HJ; Shin KC
    Anticancer Res; 2014 Jun; 34(6):3189-95. PubMed ID: 24922693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples.
    Fujimoto Y; Togo S; Tulafu M; Shimizu K; Hayashi T; Uekusa T; Honma Y; Namba Y; Takamochi K; Oh S; Suzuki K; Takahashi K
    Int J Clin Exp Pathol; 2015; 8(9):10523-33. PubMed ID: 26617762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
    Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
    Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
    Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
    J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
    Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of Smoking on the Histological Subtype and Outcome of the Primary Lung Adenocarcinoma].
    Xu Y; Tan WW; Fan P; Yang ZZ; Zhang S; Xi JL; Wang YX; Hu X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):867-871. PubMed ID: 31880119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.